Marksans Pharma’s arm gets marketing authorization for two products

17 Nov 2025 Evaluate

Marksans Pharma’s wholly owned subsidiary -- Relonchem in UK has received marketing authorization for its Mefenamic Acid 250 mg Film-Coated Tablets and Mefenamic Acid 500 mg Film-Coated Tablets from UK Medicines & Healthcare products Regulatory Agency (UK MHRA). 

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.

Marksans Pharma Share Price

169.95 1.00 (0.59%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×